secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profusa, Inc. (PFSA)
CIK:        0001859807
Form:       8-K
Filed at:   2026-04-06T23:59:59+00:00
Accession:  0001213900-26-040111
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profusa signs LOI to buy PanOmics assets for $30M equity; issues $555k convertible note
--------------------------------------------------------------------------------

- Non-binding LOI to acquire Bio Insights' PanOmics assay for $30M in stock (460k common + 59.54M conversion shares) plus 3% annual net revenue royalty.
- Issued $555,556 senior secured convertible note to Ascent (12% interest, due 2027, convertible at $0.50) and warrant for 1.11M shares at $0.50.
- Amendment No. 4 allows up to $12.2M additional notes with at least 10% OID; $1.67M principal release condition.
- Acquisition requires shareholder vote by June 30, 2026 and $10M equity financing within 30 days post-closing.
- Bio Insights gets one board nominee; management retention shares (12% fully diluted) for CEO/CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/0001213900-26-040111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/ea0285151-8k_profusa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-040111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer